Literature DB >> 35797802

Liquid chromatography method for simultaneous quantification of ATP and its degradation products compatible with both UV-Vis and mass spectrometry.

Andrew S Law1, Paul S Hafen1, Jeffrey J Brault2.   

Abstract

ATP and its degradation products are essential metabolic and signaling molecules. Traditionally, they have been quantified via high-performance liquid chromatography (HPLC) with UV-Vis detection while utilizing phosphate buffer mobile phase, but this approach is incompatible with modern mass detection. The goal of this study was to develop an ultra-performance liquid chromatography (UPLC) method free of phosphate buffer, to allow for analysis of adenine nucleotides with UV-Vis and mass spectrometry (MS) simultaneously. The final conditions used an Acquity HSS T3 premier column with a volatile ammonium acetate buffer to successfully separate and quantify ATP-related analytes in a standard mixture and in extracts from non-contracted and contracted mouse hindlimb muscles. Baseline resolution was achieved with all 10 metabolites, and a lower limit of quantification down to 1 pmol per inject was observed for most metabolites using UV-Vis. Therefore, this method allows for the reliable quantification of adenine nucleotides and their degradation products via UV-Vis and their confirmation and/or identification of unknown peaks via MS.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ATP; Adenine nucleotides; Mouse; Muscle; UPLC/MS

Mesh:

Substances:

Year:  2022        PMID: 35797802      PMCID: PMC9479163          DOI: 10.1016/j.jchromb.2022.123351

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.318


  33 in total

Review 1.  Regulating ATP turnover rates over broad dynamic work ranges in skeletal muscles.

Authors:  P W Hochachka; G O Matheson
Journal:  J Appl Physiol (1985)       Date:  1992-11

2.  Mammalian skeletal muscle fibers distinguished by contents of phosphocreatine, ATP, and Pi.

Authors:  M J Kushmerick; T S Moerland; R W Wiseman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

3.  Chemometrics for comprehensive analysis of nucleobases, nucleosides, and nucleotides in Siraitiae Fructus by hydrophilic interaction ultra high performance liquid chromatography coupled with triple-quadrupole linear ion-trap tandem mass spectrometry.

Authors:  Guisheng Zhou; Mengyue Wang; Renjie Xu; Xiao-Bo Li
Journal:  J Sep Sci       Date:  2015-09-10       Impact factor: 3.645

4.  A severe peak tailing of phosphate compounds caused by interaction with stainless steel used for liquid chromatography and electrospray mass spectrometry.

Authors:  Akira Wakamatsu; Kentaro Morimoto; Masao Shimizu; Shinobu Kudoh
Journal:  J Sep Sci       Date:  2005-09       Impact factor: 3.645

5.  Disturbed purine nucleotide metabolism in chronic kidney disease is a risk factor for cognitive impairment.

Authors:  Muhammed Khairujjaman Mazumder; Banashree Chetia Phukan; Aradhana Bhattacharjee; Anupom Borah
Journal:  Med Hypotheses       Date:  2017-12-13       Impact factor: 1.538

6.  Purine salvage to adenine nucleotides in different skeletal muscle fiber types.

Authors:  J J Brault; R L Terjung
Journal:  J Appl Physiol (1985)       Date:  2001-07

7.  Changes in cardiac nucleotide metabolism in Huntington's disease.

Authors:  Marta Toczek; Barbara Kutryb-Zajac; Paulina Zukowska; Ewa M Slominska; Mark Isalan; Michal Mielcarek; Ryszard T Smolenski
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2016-12       Impact factor: 1.381

8.  Purine nucleoside formation in rat skeletal muscle fiber types.

Authors:  P G Arabadjis; P C Tullson; R L Terjung
Journal:  Am J Physiol       Date:  1993-05

9.  Adenine nucleotide degradation in slow-twitch red muscle.

Authors:  P C Tullson; D M Whitlock; R L Terjung
Journal:  Am J Physiol       Date:  1990-02

Review 10.  Purines, purinergic receptors, and cancer.

Authors:  Francesco Di Virgilio
Journal:  Cancer Res       Date:  2012-10-22       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.